This promotional image featuring the title, date, and time of presentation at AACR 2026.
Starting soon at #AACR26: Dr. Jian Carrot-Zhang will present on germline determinants of cancer progression using multi-ancestral real-world data. @mskcancercenter.bsky.social @theaacr.bsky.social
⏰ 10:56 a.m. PDT
https://bit.ly/4u0QPRq
Join MSK senior research scientist Shiv Verma for his session on “STARD13-LATS2 Axis as a potential genetic modifier of BRCA2 in #breastcancer” TODAY at #AACR26. @theaacr.bsky.social
⏱️: Tuesday, April 21 at 4:05pm PDT
Learn more: https://bit.ly/4e2pFVC
This promotional graphic for Dr. Schrag's presentation at AACR 2026 that includes presentation title, date, and time. .
Closing out an amazing day of #cancerresearch advances at #AACR26: Our chair Dr. Deb Schrag will share her expertise on leveraging novel technologies & knowledge bases to optimize success in clinical trials. @mskcancercenter.bsky.social @theaacr.bsky.social
⏰ 5:25 p.m. PDT
https://bit.ly/4cytwXP
Join MSK leukemia specialist Dr. @oawlab.bsky.social for his session about "RNA processing regulation of anti-tumor immune responses" TODAY at #AACR26. @theaacr.bsky.social
⏱️: Tuesday, April 21 at 1:25pm PDT
Learn more: https://bit.ly/4tq8pyphttps://bit.ly/4tq8pyp
Join MSK senior research scientist Peng Li for her session on “Evasion of hepatic ILC1 immunosurveillance drives #breastcancer liver metastasis” TODAY at #AACR26. @theaacr.bsky.social
⏱️: Tuesday, April 21 at 2:35pm PDT
Learn more: https://bit.ly/42moitC
Join MSK research scholar Silvia Palladino for her session on “Combining RAS inhibitors with the clinical RNR inhibitor BBI-825 to prevent the emergence of extrachromosomal DNA (ecDNA)-driven resistance to RAS-targeted therapies in #colorectalcancer” TODAY at #AACR26. @theaacr.bsky.social
MSK gastrointestinal medical oncologist Dr. Eileen O'Reilly led a very promising phase 1/2 clinical trial of the targeted RAS therapy #daraxonrasib for people facing #pancreaticcancer.
Learn more about this research presented at #AACR26: https://bit.ly/4coBGmW
@theaacr.bsky.social
This is a promotional graphic for a presentation by a member of the MSK Department of Medicine at AACR 2026 featuring the presenter photo, presentation title, time, and date.
Don't miss this presentation at #AACR26: Dr. Joseph Minhow Chan on basal-state origins and genotype-specific trajectories of neuroendocrine plasticity in #lungcancer. @mskcancercenter.bsky.social @theaacr.bsky.social
⏰ 3:35 p.m. PDT
https://bit.ly/42g9nkz
A promotional graphic for MSK Department of Medicine at AACR 2026. The topic is immune and clinical determinants of response to immune checkpoint blockade re-challenge after perioperative chemoimmunotherapy in gastroesophageal cancer. The event is on Tuesday, April 21, at 2:00 p.m. PDT. There is a portrait of Jeremy Tchack, MD, Research Fellow, from Memorial Sloan Kettering Cancer Center.
Coming up at #AACR26: Dr. Jeremy Tchack will present a poster on immune and clinical determinants of response to ICB rechallenge after perioperative chemoimmunotherapy in #gastroesophagealcancer. @mskcancercenter.bsky.social @theaacr.bsky.social
⏰ 2 p.m. PDT
https://bit.ly/4874iyz
Join MSK breast medical oncologist Dr. Sarat Chandarlapaty for a session about “Resistance to anti-HER2 ADCs” TODAY at #AACR26. @theaacr.bsky.social
⏱️: Tuesday, April 21 at 1:25pm PDT
Learn more here: https://bit.ly/4934sY2
#AACR26
Join gastrointestinal medical oncologist Dr. Luis Diaz for his session about “Chemical engineering of mismatch repair deficiency to induce tumor immunogenicity” TODAY at #AACR26. @theaacr.bsky.social e
⏱️: Tuesday, April 21 at 1:25pm PDT
Learn more: https://bit.ly/4cueKBm
Join principal investigator @caleblareau.bsky.social for a session about “Population scale sequencing resolves the determinants and consequences of persistence #EpsteinBarrVirus infection” TODAY at #AACR26.
⏱️: Tuesday, April 21 at 1pm PDT
Learn more here: https://bit.ly/4mKNiUS
On the #AACR26 stage this morning: Dr. Yelena Janjigian, Chief of MSK's Gastrointestinal Oncology Service, will share her expertise on the latest advances in #cancer #immunotherapy. @mskcancercenter.bsky.social @theaacr.bsky.social
⏰ 10:15 a.m. PDT
https://bit.ly/4exbXKp
Kicking off today's poster session at #AACR26: Dr. Brian Chernak will share phase I results on ruxolitinib + the CDK4/6 inhibitor abemaciclib in previously treated #myelofibrosis. @mskcancercenter.bsky.social @theaacr.bsky.social
⏰ 9 a.m.–12 p.m. PDT
https://bit.ly/4dRLPK1
Join MSK leukemia specialist Dr. Omar Abdel-Wahab for a session about “From molecules to medicine – driving breakthroughs in blood cancer treatment” TODAY at #AACR26.
⏱️: Monday, April 20 at 6:45pm PDT
Learn more here: https://bit.ly/48Z0tf3
Happening soon at #AACR26: Dr. David Solit is leading a session sharing how the @theaacr.bsky.social international registry Project GENIE® is advancing #cancer research. @mskcancercenter.bsky.social
⏰ 2:30 p.m. PDT
https://bit.ly/4sIBMuB
Up next at #AACR26: Dr. Juan Osorio is chairing a session on advances in therapeutic antibodies, a rapidly evolving frontier in #cancer care. @mskcancercenter.bsky.social @theaacr.bsky.social @juanosoriomd.bsky.social
⏰ 2:30 p.m. PDT
https://bit.ly/4myt3tk
MSK radiochemist @lewislabmskcc.bsky.social shared an insightful presentation about questions and new opportunities in #theranostics at #AACR26. @theaacr.bsky.social
Join Dr. Vinod Balachandran, an MSK physician-scientist and Director of The Olayan Center for Cancer Vaccines, for a Major Symposium sharing new research about “Personalized neoantigen vaccines for #pancreaticcancer” TODAY at #AACR26. @theaacr.bsky.social
Learn more: https://bit.ly/4vMl7ZY
Join MSK radiochemist Dr. @lewislabmskcc.bsky.social for a session about “New questions and new opportunities in theranostics” TODAY at #AACR26. @theaacr.bsky.social
Monday, April 20 at 10:36am PDT
Learn more here: https://bit.ly/4dTR0cr
Join MSK's Dr. Kevin Boehm for a session about “Multimodal modeling of detailed cancer subtypes and molecular features from >60,000 patients with co-registered H&E images and clinical tumor sequencing” TODAY at #AACR26. @theaacr.bsky.social
⏱️: Sunday, April 19 3:05pm PDT
https://bit.ly/4vGnhdn
An experimental vaccine using #mRNA to prevent #pancreaticcancer from returning after surgery continues to show promise in a 16-person patient group.
Results show that nearly 90% of people whose immune systems responded to the vaccine were still alive 6 years later.
https://bit.ly/3Oebu5n
Join MSK gastrointestinal medical oncologist Dr. Yelena Janjigian for a session about “Resectable gastroesophageal cancer: Time to rewrite the standard” TODAY at #AACR26. @theaacr.bsky.social
⏱️: Sunday, April 19 at 1:25pm PT
Learn more here: https://bit.ly/4ew74kO
Join MSK leukemia specialist and physician-scientist Dr. Ross Levine for a session titled “Targeting epigenetic dependencies in myeloid malignancies” TODAY at #AACR26.
⏱️ : Sunday, April 19 at 1:30pm PDT
Learn more here: https://bit.ly/4mG5f79
Join MSK computation biologist Dana Pe’er for a session about “When form meets function: Decoding tissue architecture” TODAY at #AACR26.
⏱️: Sunday, April 19 at 1:30pm PDT
Learn more here: https://bit.ly/4tpoqVg
Join MSK genitourinary medical oncologist Dr. David Solit for a session about “Advancing target discovery for rare cancers through institutional-scale molecular profiling and social media outreach” TODAY at #AACR26. @theaacr.bsky.social
⏱️: Sunday, April 19 at 1:55pm PDT
https://bit.ly/4cznSov
Next up at #AACR: Join MSK gynecologic medical oncologist Dr. Rachel Grisham for a session titled “Approaches to drug development for rare malignancies” TODAY. @theaacr.bsky.social
⏱️: Sunday, April 19 at 1:30pm PDT
Learn more here: https://bit.ly/41F7aPF
Dr. Duaa Al-Rawi will present a poster on multimodal profiling of serous tubal intraepithelial carcinoma lesions to identify precursor states with genomic features of high-grade serous #ovariancancer. #AACR26 @mskcancercenter.bsky.social @theaacr.bsky.social
⏰ 2–5 p.m. PDT
https://bit.ly/4vxuBrP
Coming up at #AACR26: Meet Dr. Luis Diaz, Editor-in-Chief of @CD_AACR and Head of MSK's Division of Solid Tumor Oncology, at the AACR Publications Booth 3537 in Hall D. @mskcancercenter.bsky.social @theaacr.bsky.social
⏰ 2 p.m. PDT
https://bit.ly/4eonJ9W
#AACRFellows and Past President Charles L. Sawyers discusses "How Cancer Cells Escape Targeted Therapy by Changing Identity" during the Opening Plenary Session at #AACR26.